Complaint & PMS Governance Services
Strengthen complaint handling, reportability decisions, and post-market surveillance with expert governance support for medical device manufacturers. Elexes helps teams build defensible workflows, improve closure quality, connect complaints to CAPA and risk management, and stay aligned with FDA, EU MDR, ISO 13485, and global post-market expectations across the full device lifecycle.
Our Complaint & PMS Governance Services
Focused post-market governance services that improve complaint quality, reporting readiness, and surveillance oversight.
Complaint Governance
Oversight for complaint intake, classification, investigation quality, closure documentation, and lifecycle consistency to help manufacturers maintain compliant, defensible complaint handling processes.
Reportability Support
Structured assessment of adverse events and malfunctions against FDA MDR, EU vigilance, and other reporting criteria, with support for timely, accurate submissions.
PMS Signal Review
Periodic analysis of complaint and post-market data to identify trends, emerging safety signals, and issues that should feed CAPA, risk management, and surveillance reports.
Post-Market Surveillance
Support for active PMS programs, including data consolidation, trending, PMSRs, PSURs, and governance practices that keep surveillance outputs current and actionable.
Change Impact
Evaluation of product, process, software, or labeling changes to determine regulatory impact and ensure post-market decisions remain aligned with authorized device status.
RAQA Operations
Embedded regulatory and quality support that extends internal teams with ongoing governance, documentation control, and post-market compliance execution.
Our Complaint Governance Process
Intake and Record Review
We review incoming complaint records for completeness, product linkage, event details, and initial classification so your team starts with a clean, traceable file and the right escalation path.
Investigation and Triage Oversight
Our consultants assess investigation scope, timelines, and evidence quality against 21 CFR Part 820.198, ISO 13485, and applicable vigilance expectations to reduce weak or delayed investigations.
Reportability Decision Support
We evaluate whether events trigger FDA MDRs, EU MDR vigilance reports, or other notifications, documenting the rationale clearly so decisions are timely, consistent, and audit-defensible.
Trend and Signal Analysis
Complaint data is analyzed for recurring issues, lot patterns, device family trends, and emerging safety signals that may require CAPA, risk updates, or broader post-market action.
Closure and System Integration
We verify closure documentation and connect outputs to PMS reports, risk management files, clinical evaluation updates, and change assessments so post-market governance drives real quality decisions.
Trusted By Manufacturers
Proven Results
Supporting medical device teams with structured governance, stronger documentation, and audit-ready post-market operations.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Elexes brings deep regulatory and quality expertise to complaint handling and post-market governance.
Deep Expertise
50+ years of collective experience across FDA, EU MDR, ISO 13485, and global device compliance.
End-to-End Support
From complaint intake to PMS outputs, Elexes supports the full post-market governance lifecycle.
Audit Readiness
Structured oversight improves documentation quality, closure discipline, and readiness for inspections and audits.
Flexible Delivery
Choose project-based, part-time, or embedded RAQA support without adding permanent internal headcount.
Meet The Elexes Team
Experienced regulatory and quality specialists for medical devices.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with practical regulatory and quality expertise across the full product lifecycle. The company has built its reputation by helping organizations navigate approvals, quality system demands, and post-market obligations with greater clarity and control. For complaint handling and PMS governance, Elexes applies the same disciplined approach: strengthening intake, investigation, reportability, trending, and integration with CAPA and risk management. Backed by 50+ years of collective experience, the team supports global manufacturers across FDA, EU MDR, Health Canada, TGA, and other frameworks. With 250+ successful projects, work across 200+ product types, and a 90% audit clearance rate, Elexes delivers governance support designed to be operational, defensible, and scalable.
200+ Product TypesExperience spanning diverse medical device categories.90% Audits ClearedStrong track record supporting inspection and audit readiness.250+ Successful ProjectsDelivered across regulatory, quality, and post-market engagements.
Frequently Asked Questions
What are the types of medical device complaints?
Medical device complaints commonly include product malfunctions, labeling issues, packaging defects, use errors, adverse events, performance failures, and quality concerns reported by customers or users. They may be reportable or non-reportable depending on the event details and regulatory criteria. A strong complaint system classifies each complaint accurately, documents the investigation, and links findings to CAPA, risk management, and post-market surveillance activities.
What are the 5 steps of the complaint process?
The five core steps are intake, evaluation, investigation, reportability assessment, and closure. Intake captures complete event details. Evaluation confirms classification and severity. Investigation determines cause and supporting evidence. Reportability assessment checks whether FDA MDR, EU vigilance, or other submissions are required. Closure documents conclusions, actions taken, and any links to CAPA, PMS trending, or risk file updates.
Why is complaint handling important for medical device manufacturers?
Complaint handling is critical because it directly affects patient safety, regulatory compliance, and market continuity. Regulators expect manufacturers to review complaints promptly, investigate appropriately, assess reportability, and identify trends that may indicate broader safety issues. Weak complaint handling can lead to missed reporting deadlines, audit findings, CAPA failures, and enforcement actions that disrupt commercial operations.
How does complaint governance connect to post-market surveillance?
Complaint governance is a core input to post-market surveillance because complaint records often reveal recurring failures, adverse trends, and emerging safety signals. Those findings should feed PMS reports, PSURs, PMSRs, CAPA decisions, and risk management updates. When complaint handling and PMS are integrated, manufacturers can move beyond isolated case review and maintain a more proactive, evidence-based post-market system.
When does a complaint become reportable?
A complaint becomes reportable when the event meets the criteria defined by the applicable authority, such as FDA MDR requirements under 21 CFR Part 803 or EU MDR vigilance obligations. This usually involves death, serious injury, or a malfunction that could lead to serious harm if it recurred. A documented reportability assessment should evaluate event facts, device involvement, severity, and regulatory timelines.
What should be included in a medical device complaint investigation?
A complaint investigation should include the event description, device identification, lot or serial details, initial classification, evaluation of returned product if available, root cause analysis where appropriate, reportability determination, and documented conclusions. It should also show whether corrective actions, CAPA, labeling review, supplier review, or risk file updates were considered. The record must be complete enough to withstand audit and inspection scrutiny.
How often should complaint trends and PMS signals be reviewed?
Trend review frequency should match the device risk profile, complaint volume, and regulatory commitments, but many manufacturers review monthly or quarterly. Higher-risk devices or rapidly growing portfolios may require more frequent analysis. Reviews should look for recurring failure modes, lot-specific issues, geographic patterns, and severity shifts. The output should be documented and tied to management review, CAPA, and post-market reporting obligations.
Can outsourced complaint and PMS governance still meet regulatory expectations?
Yes, outsourced governance can meet regulatory expectations when responsibilities, review criteria, timelines, and documentation standards are clearly defined. The manufacturer still retains ultimate responsibility, but an experienced external partner can strengthen consistency, improve investigation quality, support reportability decisions, and maintain surveillance discipline. The key is having auditable workflows, clear oversight, and integration with the manufacturer’s quality system and regulatory obligations.
Still Have Post-Market Questions?
Talk with Elexes about complaint handling and PMS governance support.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Supports multi-market audit readiness.
IEC 62304
Software lifecycle compliance capability.
